Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
scientific article
Author/s
author: Peter Hau, Louis B Nabors, Monika E Hegi, Michael Weller, Wolfgang Wick, David A Reardon, Astrid Weyerbrock, Rafał Tarnawski, Alba A. Brandes, Tejpal Gupta, Martin J van den Bent, Kenneth D Aldape, Rolf-Dieter Kortmann, Roger Stupp, Thierry Gorlia, Sara C Erridge, Ulrich Herrlinger, Catherine McBain, Jörg-Christian Tonn, Martin Taphoorn
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.